Roche news in 2026: 38 dated events
The latest Roche event on this page is dated Oct 28, 2026. globenewswire.com reported: Roche strengthens cancer diagnostic portfolio with launch of test for differential diagnosis of mesothelioma.
Get Roche's live signals in Claude or ChatGPT, or by API
What changed at Roche this week? Use Autobound signals for roche.com.- Dated events
- 38
- Last 90 days
- 31
- Latest
- Oct 28, 2026
Source: Autobound Signal API · 87 signals tracked for Roche · updated
News · latest 10
Latest Roche news
Showing 10 of 38 dated events. The Signal API returns all of them.
Get them with one API call- Roche strengthens cancer diagnostic portfolio with launch of test for differential diagnosis of mesotheliomaRoche has launched the VENTANA BAP1 (SP527) test, an automated immunohistochemistry diagnostic assay to identify mesothelioma.
- Roche receives CE Mark for cobas® smart e immunoanalyser, completing a portfolio that brings central-lab precision to healthcare settings ranging from small clinics to large...Roche received the CE Mark for its cobas smart e immunoanalyser platform.
- [Ad hoc announcement pursuant to Art. 53 LR] Roche continues strong momentum in the third quarter with sales growth of +7% at constant exchange rates (CER) and +8% in CHF...Roche reported Group sales of CHF 46.5 billion in the first nine months of 2026, an increase of 6% at constant exchange rates.
- Roche's new Mannheim calling cardRoche has opened a new 1,500-square-meter reception building, the Gatehouse, and an adjacent landscape park at its plant site in Mannheim, Germany.
- A daily pill to fight breast cancer? Swiss firm’s new drug completes 3 phases of human trialsF. Hoffmann-La Roche AG is seeking US approval for its breast cancer pill giredestrant following the completion of Phase III trials.
- Roche acquires Chinese antibody-drug conjugate rights for $500mWith Hansoh Pharma
- Roche to present pivotal data at ESMO 2026, showcasing advances across its lung and breast cancer late-stage portfolioRoche showcased Phase III clinical results for its cancer drug Divarasib in advanced lung cancer.
- Roche acquires a Chinese obesity drug for 1.037 billionWith Rona Therapeutics
- Roche closes the acquisition of a Chinese obesity drug for 1.037 billion$1.2B · With Rona Therapeutics
- Roche Gets FDA Approval for Another Label Expansion of TecentriqThe FDA approved Roche's Tecentriq and Tecentriq Hybreza in combination with chemotherapy for the adjuvant treatment of stage III dMMR colon cancer.
Showing 10 of 38 dated events. The Signal API returns all of them.
Get them with one API callSignal API · MCP
Track Roche with the Signal API
One POST /v1/companies/enrich call with roche.com returns Roche news signals (news), each with its source. Or ask Claude through MCP.
2 credits per signal returned; zero-result calls are free. Endpoint reference
curl -X POST https://signals.autobound.ai/v1/companies/enrich \
-H "X-API-KEY: $AUTOBOUND_API_KEY" \
-H "Content-Type: application/json" \
-d '{"domain":"roche.com","signal_types":["news"],"limit":20}'Bulk data
Need this signal for 10,000+ companies?
Get a free sample file or a bulk feed (API, GCS push, flat file). The sample is real News records, as a CSV.
Same industry
News at related companies
Questions about Roche news
What is the latest news on Roche?
What is going on with Roche?
Page updated , the date of the newest row on this page.
Source. News articles about the company, one source link per event.
Method. Stories about the same event within 14 days merge into one row. Noise (lists, stock tips, recaps) is removed.
Data as of .